MedTrace Logo

Endostar Combine With Radiotherapy in Brain Metastasis of NSCLC

NCT03614065 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2018-08-03

No results posted yet for this study

Summary

Observe the effect os radiotherapy plus or not plus endostar in the treatment of brain metastasis in NSCLC

Conditions

Interventions

DRUG

endostar

endostatin

DRUG

Placebos

saline solution

RADIATION

radiotherapy

radiotherapy

Sponsors & Collaborators

  • Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

    lead OTHER

Principal Investigators

  • dong xiaorong, Dr · china goverment

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-02-21
Primary Completion
2018-11-30
Completion
2018-11-30

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03614065 on ClinicalTrials.gov